Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Monthly Investment Strategy

March Op-Ed: Who can resist market contagion?

  • 24 March 2021
  • 7 min read

Key points

  • US long-term yields should continue to rise in the near-term as inflation is likely to rise, a least transitorily. Europe is fighting contagion. Fragile EMs are in the worst position are being forced into pro-cyclical monetary tightening.
  • Strong growth, low rates challenge markets
  • But reflation keeps driving markets
  • US bond yields beginning to be interesting

Central banks tolerance tested

The silence of the Fed is deafening when it comes to addressing the ongoing rise in US long-term yields. True, the central bank is maintaining an ultra-accommodative forward guidance, with the “dot plot” showing the median member of the Federal Open Market Committee (FOMC) still ready to wait until 2024 to hike rates and Jay Powell making it plain that the market will be warned well in advance before the Federal Reserve (Fed) starts tapering its purchases of bonds. But paradoxically this fuels a relentless pressure on market interest rates given the Fed’s benign approach to inflation – their forecasts explicitly contain a phase of target overshooting. The Fed’s dovishness is designed to make long-term inflation expectations rise. To stop pushing yields up, the market would want to hear the Fed talk about “operation Twist” and alter its bond purchasing framework to control the long end of the curve, but for now the Fed is not making any signals towards such a shift.

Beyond the impact of the Fed’s expected stance, inflation concerns are underpinned by the dataflow from the business sector. The price component of the non-manufacturing ISM index hit its highest level in February since 2009, in a range which in the past has been consistent with actual acceleration in core inflation within a 3 to 6 months horizon. The fact that the US administration managed to push through Congress a nearly intact USD1.9tn fiscal stimulus is adding to the probability that the US is soon to go through an “overheating phase”, as the fiscal support will coincide with the reopening of the economy thanks to the swift implementation of the vaccination programme.

Fundamentally, the Fed’s approach is sound. The Biden push will be short-lived. We don’t know if he will have political capital left to get his medium-term investment package implemented later-on, while the rise in long-term interest rates is reducing the attractiveness of such a strategy – it is getting more difficult to argue it will “pay for itself”. By year-end the US economy is likely to be more sedate, and Biden’s failure to tag his steep rise in minimum wage on the stimulus bill will help keep the risks of a cost-push inflation shock in check. Still, in the meantime, the market is likely to be trading on “confirmation bias” as, at least transitorily, consumer prices will accelerate. We think 10-year yields will continue rising to 2% before slightly receding.

The US economy can probably withstand the ongoing tightening in financial conditions, but any significant contagion to Europe would come at the wrong time. For now, the Euro area is faced with stricter, not looser mobility restrictions as the propagation of the virus is accelerating and the vaccination programme remains slow. Moreover, while fiscal policy is accommodative in Europe, focus is more on a medium-term accompaniment to the recovery with mutualised EU transfers than on big, spectacular short-term packages. The European Central Bank (ECB) has pledged to stand in the way of contagion by accelerating the disbursements under the Pandemic Emergency Purchase Programme (PEPP), but some disagreements appear to be emerging within the central bank. It seems that now it takes a Governing Council meeting, plus preferably a new set of forecasts – which comes only once a quarter - for any decision on this front to be made. This will make the ECB more reactive than pre-emptive, which is consistent with volatility episodes, even if we think that the current Bund/Treasury spread should be maintained on the whole and we expect the German 10-year yield to remain negative by year-end.

Emerging markets are at risk in such a configuration, and capital outflows are starting. Overall, their financial position is stronger than in many episodes of interest rate reappraisal in developed markets, but as usual the most fragile ones are under pressure. We can see central banks forced into hiking rates, most recently in Turkey, Russia and Brazil, to the detriment of the post-pandemic recovery. Turkey in particular is the one to watch since the country seems to have reached the point beyond which political authorities are no longer ready to accept the price of monetary tightening. This is the recipe for significant financial stability turmoil.

Navigating higher yields (in an optimistic way)

Investors mostly share a positive view of the macro-economic outlook. The recovery differs in magnitude and veracity from economy to economy but with both the US and China expected to grow at rates well above trend for the foreseeable future, it is not unreasonable to have a bullish global view. Ordinarily this would support a significant allocation to risky assets. Indeed, even though there are nuances to be considered at this part of this particular cycle, that does still seem to be the right strategy. Strong nominal growth will support earnings growth and equities into 2022. Credit markets will benefit from deleveraging as earnings grow and a continued supportive financing environment. At the lower quality end of the US bond market, defaults are not likely to reverse higher again with the economy growing so strongly. The emerging market story is more complicated, but some regions can benefit from high growth in developed markets.

As noted above, the uncertainties continue to centre around the US inflation and interest rate outlook. Some investors struggle with the idea that the US Federal Reserve will let inflation move to levels not seen since the credit boom that pre-dated the global financial crisis. The message from Washington is no rate hikes this side of the end of 2023. Strong growth, higher inflation and no rate hikes! This untested policy approach has generated an aggressive steepening of the US yield curve the likes of which have only been seen when the Fed has been cutting interest rates. Higher longer-term yields reflect the “normalisation” of the growth and inflation cycle, stable short-term rates reflect the Fed’s resolve to make sure this happens. For the moment, bond investors have not reached a settlement with this new orthodoxy.

The slope of the yield curve, inflation break-evens and real yields could increase further, absent some form of “operation twist”. Reading across to the equity markets, this should underpin the recent outperformance of cyclicals that will benefit from increased demand and better pricing power. Further nuances are provided by the interaction of cyclical and secular forces that will play out in equity markets. The current shortage of semi-conductors is a case in point. Supply is likely to have been disrupted over the last year and capacity seems challenged in the face of increased secular demand from ramped-up electronic vehicle production plans and the broader role digitalisation is playing in the energy transition. Spot prices for semis have been increasing in accordance. Investors should also take note of the significant investment in adding more renewable energy and battery storage capacity. The benefits to the entire supply chain will be clear but this could also highlight some bottlenecks and price pressures. This coming at a time when oil and other commodity prices have risen sharply. Our view is that the secular inflation outlook is not materially changed but there will be noise as the global economy recovers.

The US will be the key focus as it surges out of the COVID slump. The rise in yields is already making US fixed income more attractive, but there could be some way to go before reflation is fully priced. Even now though, US bonds hedged into euros or yen are at their most attractive levels of yield for some time. Duration hungry global investors are likely to take advantage. On the equity side, the dominance of US growth over the next 19-24 months makes us wonder if the modestly better local currency performance of Europe over the US market can be sustained when the clear economic outperformance of the US is written large in the coming data. The US consumer is coming back with gusto and the rising tide of spending should lift all boats. So far, the rise in bond yields is less important than the potential spending boom.

Download the full deck of our March Investment Strategy
Download Deck (3.6 MB)

Related Articles

Monthly Investment Strategy

May Op-Ed - Inflation anxiety

  • 21 May 2021
  • 7 min read
Monthly Investment Strategy

May Global Macro Monthly - The limitation of vaccinations

  • 21 May 2021
  • 7 min read
Monthly Investment Strategy

The return of inflation is a US story

  • 23 April 2021
  • 5 min read
Are you a financial advisor, institutional, or other professional investor?

This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This promotional communication does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee that forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested.